Animal Research Concerns

Heart surgeon Michael DeBakey is outraged because of a question on the SAT tests, the correct answer to which suggests that there is some abuse of animals in scientific research, and that concern about the problem is long overdue (The Scientist, Sept. 16, 1991, page 3). The fact is that scientists themselves have voiced concerns. In 1952, Robert Gesell, then chairman of the department of physiology at the University of Michigan, said at a meeting of the American Physiological Society: "Conside

Written byMarjorie Anchel
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The fact is that scientists themselves have voiced concerns. In 1952, Robert Gesell, then chairman of the department of physiology at the University of Michigan, said at a meeting of the American Physiological Society: "Consider what we are doing in the name of science," and pointed out the worst abuses. These experiments were defended by the National Society for Medical Research, now called the Foundation for Biomedical Research, of which DeBakey is chairman.

In 1977, the Federation of American Scientists' Public Interest Report pointed out that no restraints comparable to those imposed when medical science is practiced on humans "operate to remind the animal experimenter to limit animal suffering and stress to the minimum necessary to the human goal."

Since that time, some restraints have been imposed by law. But at least six groups of scientists concerned about the continuing abuse of experimental animals have been formed (Association of Veterinarians ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies